Flora Growth Appoints Dr. Annabelle Manalo-Morgan, PhD, as Lead Scientific Advisor and Forms Science Advisory Team
June 17 2021 - 7:30AM
Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a
leading all-outdoor cultivator and manufacturer of global cannabis
products and brands, has appointed Dr. Annabelle Manalo-Morgan,
PhD, as Lead Scientific Advisor to further the research and
development of unique product formulations and to educate
individuals on the benefits of cannabinoid and plant-based
medicine.
Dr. Annabelle is a scientist, educator, author,
mother of five, and a respected key opinion leader. She is a
cell and developmental biologist from Vanderbilt
University in Nashville, Tennessee, with a
background in neuroscience from Georgetown University. She
earned her PhD in Cell and Developmental Biology with a focus in
Cardio-Oncology and has since become a philanthropist and
entrepreneur focused on pharmaceutical innovation and clinical
trial research in medical cannabis.
"We are very pleased to welcome Dr. Annabelle to
the Flora Growth team where she will be instrumental in the future
of Flora’s product development, research and educational efforts,"
said Luis Merchan, President and CEO of Flora. “Flora has
always been very passionate about its medical divisions and views
them as foundational components of the Company as it expands its
global presence. The formation of this advisory team led by Dr.
Annabelle will streamline our research and development efforts and
help speed up growth initiatives as we work together to launch
targeted cannabis products and increase distribution across all
channels.”
During her training, Dr. Annabelle experienced
life-changing personal trauma that shifted her focus toward
alternative medicine and natural health consciousness. Over the
past 6 years, she has dedicated herself to educating individuals
worldwide on the complexity of disease and the significance of
utilizing natural components of plants, such as cannabis, to make
medicine a more efficient, safe and personalized process. She
consults on medical cannabis legalization, standards and protocols
for a variety of countries and firms, and is currently conducting
advanced research and product development focused on the
therapeutic application of specific cannabinoids in disease
conditions.
“The need for research and innovative product
development has never been greater as the cannabis industry
continues its exponential growth and acceptance around the world.
Current solutions often leave consumers, patients and healthcare
professionals with few options aside from a low-and-slow approach
while trialing numerous products and product formats,” added Dr.
Annabelle. “I’m extremely excited to be working with the Flora team
as we are aligned on creating and bringing to market novel products
that have a superior safety profile and are more efficacious than
existing cannabis treatment options.”
Flora Announces CEO Fireside
Highlighting Recent Developments
Further Flora Growth will be hosting another
live fireside discussion between President & CEO, Luis Merchan,
and Vice President of Corporate Development, James Williams. The
virtual fireside conversation will take place on Thursday, June
24th at 1:00 pm ET and all those interested in attending are
encouraged to register using the following link.
Registration
Link:https://us02web.zoom.us/webinar/register/WN_9dTiVRXpQ0qfKOIBXJBSdQ
Specifically, Luis and James will provide an
overview of the recent Hoshi and Heimat announcements, including
their strategic importance to our international expansion and
expected contributions to our revenue growth. They will also
discuss the latest management additions and outline Flora Growth's
approach to securing exceptional human capital to execute on its
growth plans.
About Flora Growth Corp.
Flora is a cannabis company that leverages
natural, cost-effective cultivation practices to supply cannabis
derivatives to its diverse business divisions of cosmetics, hemp
textiles, and food and beverage. As the operator of one of the
largest outdoor cultivation facilities, Flora strives to market a
higher-quality premium product at below market prices. By
prioritizing natural ingredients and value-chain sustainability
across its portfolio, Flora creates premium products that help
consumers restore and thrive. Visit www.floragrowth.ca or follow
@floragrowthcorp on social for more information.
Investor Relations Contact:Evan Veryard +1 416
571 9037evan.veryard@floragrowth.ca
Public Relations Contact:Cassandra Dowell+1
(858) 264-6600flora@cmwmedia.com
Cautionary Statement Concerning Forward-Looking
Statements
This document contains forward-looking
statements. In addition, from time to time, we or our
representatives may make forward-looking statements orally or in
writing. We base these forward-looking statements on our
expectations and projections about future events, which we derive
from the information currently available to us. Such
forward-looking statements relate to future events or our future
performance, including: the impact of additions to our advisory
team; our financial performance and projections; our growth in
revenue and earnings; and our business prospects and
opportunities. You can identify forward-looking statements by
those that are not historical in nature, particularly those that
use terminology such as “may,” “should,” “expects,” “anticipates,”
“contemplates,” “estimates,” “believes,” “plans,” “projected,”
“predicts,” “potential,” or “hopes” or the negative of these or
similar terms. In evaluating these forward-looking
statements, you should consider various factors, including: our
ability to change the direction of the Company; our ability to keep
pace with new technology and changing market needs; and the
competitive environment of our business. These and other
factors may cause our actual results to differ materially from any
forward-looking statement. Forward-looking statements are
only predictions. The forward-looking events discussed in
this document and other statements made from time to time by us or
our representatives may not occur, and actual events and results
may differ materially and are subject to risks, uncertainties and
assumptions about us. We undertake no obligation to publicly
update or revise any forward-looking statement, whether as a result
of uncertainties and assumptions, or the forward-looking events
discussed in this document and other statements made from time to
time by us or our representatives not occurring, except as may be
required by applicable law.
Flora Growth (NASDAQ:FLGC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Flora Growth (NASDAQ:FLGC)
Historical Stock Chart
From Sep 2023 to Sep 2024